Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-04-16 @ 5:23 PM
Study NCT ID:
NCT03244956
Status:
UNKNOWN
Last Update Posted:
2021-09-28
First Post:
2017-08-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer
Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-27
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12
Completion Date Type:
ESTIMATED
First Submit Date:
2017-08-07
First Submit QC Date:
None
Study First Post Date:
2017-08-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-27
Last Update Post Date:
2021-09-28
Last Update Post Date Type:
ACTUAL